Every year, ESGCT hosts an Annual Congress where more than 100 world-renowned experts showcase their latest research. Whether they are Nobel Prize laureates or pioneers pushing the boundaries of the field, this event highlights the most current and groundbreaking research in gene and cell therapy.
Come visit us at booth #86 and discover MaxCyte's cGMP-compliant non-viral cell engineering platform and how it enables the acceleration of therapeutic development from concept to clinic.
While at the meeting, attend our feature presentation:
Next-generation CAR-based immunotherapies
Date: October 27
Time: 1:25 - 2:25 PM
Location: Shed 2B
Presenter: Prof. Michael Hudecek, MD
Significant efforts have been invested in the development of advanced genetic engineering methods for immune effector cells targeting cancer cells. In this talk, optimized virus-free gene editing strategies for CAR T cells, refinement of clinical translation and the impact on their application will be presented. Insights into future directions to accelerate and amplify production to deliver CAR products with curative potential will be explored.